Citigroup’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.35K | Buy |
913
+224
| +33% | +$1.56K | ﹤0.01% | 4509 |
|
2025
Q1 | $5.85K | Buy |
689
+59
| +9% | +$501 | ﹤0.01% | 4481 |
|
2024
Q4 | $8.82K | Sell |
630
-38
| -6% | -$532 | ﹤0.01% | 4544 |
|
2024
Q3 | $15.1K | Sell |
668
-94
| -12% | -$2.13K | ﹤0.01% | 4437 |
|
2024
Q2 | $15.4K | Buy |
762
+634
| +495% | +$12.8K | ﹤0.01% | 4318 |
|
2024
Q1 | $3.19K | Sell |
128
-15,500
| -99% | -$386K | ﹤0.01% | 4581 |
|
2023
Q4 | $283K | Buy |
15,628
+15,096
| +2,838% | +$273K | ﹤0.01% | 3025 |
|
2023
Q3 | $10.7K | Sell |
532
-71
| -12% | -$1.43K | ﹤0.01% | 3816 |
|
2023
Q2 | $15.4K | Buy |
603
+148
| +33% | +$3.78K | ﹤0.01% | 4318 |
|
2023
Q1 | $9.68K | Sell |
455
-56
| -11% | -$1.19K | ﹤0.01% | 4081 |
|
2022
Q4 | $15.1K | Sell |
511
-23
| -4% | -$681 | ﹤0.01% | 4003 |
|
2022
Q3 | $12K | Sell |
534
-55
| -9% | -$1.24K | ﹤0.01% | 4187 |
|
2022
Q2 | $10K | Sell |
589
-159
| -21% | -$2.7K | ﹤0.01% | 4617 |
|
2022
Q1 | $33K | Sell |
748
-54
| -7% | -$2.38K | ﹤0.01% | 4192 |
|
2021
Q4 | $49K | Buy |
802
+649
| +424% | +$39.7K | ﹤0.01% | 4303 |
|
2021
Q3 | $6K | Sell |
153
-913
| -86% | -$35.8K | ﹤0.01% | 4803 |
|
2021
Q2 | $32K | Buy |
1,066
+553
| +108% | +$16.6K | ﹤0.01% | 4364 |
|
2021
Q1 | $15K | Buy |
+513
| New | +$15K | ﹤0.01% | 4729 |
|